A novel mutation Gly1672 → Arg in type 2A and a homozygous mutation in type 2B von willebrand disease

Thrombosis and Haemostasis

Volumn 76, Issue 2, 1996, Pages 253-257

  Hagiwara, Takeshi ^a   Inaba, Hiroshi ^a   Yoshida, Shinichi ^a   Nagaizumi, Keiko ^a   Arai, Morio ^a   Hanabusa, Hideji ^b   Fukutake, Katsuyuki ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b Ogikubo Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RESTRICTION ENDONUCLEASE; VON WILLEBRAND FACTOR; ARGININE; DNA; GLYCINE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; EXON; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MISSENSE MUTATION; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VON WILLEBRAND DISEASE; ASIAN; CASE CONTROL STUDY; CHEMISTRY; GENETIC POLYMORPHISM; GENETICS; HOMOZYGOTE; PEDIGREE;

ARGININE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DNA; DNA MUTATIONAL ANALYSIS; EXONS; GLYCINE; HOMOZYGOTE; HUMANS; PEDIGREE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; VON WILLEBRAND DISEASE;

EID: 0029658166     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650564     Document Type: Article

References (28)

1. Jaffe EA, Hoyer LW, Nachman RL. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 1973; 52: 2757-64.
2. Nachman R, Levine R, Jaffe EA. Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest 1977; 60: 914-21.
3. Weiss HJ, Sussman II, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor: studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest 1977; 60: 390-404.
4. Ruggeri ZM, Zimmermann TS. von Willebrand factor and von Willebrand disease. Blood 1987; 70: 895-904.
5. Mancuso DJ, Tuley EA, Westfield LA, Worrall NK, Shelton-Inloes BB, Sorace JM, Alevy YG, Sadler JE. Structure of the gene for human von Willebrand factor. J Biol Chem 1989; 264: 19514-27.
6. Mancuso DJ, Tuley EA, Westfield LA, Lester-Mancuso TL, Le Beau MM, Sorace JM, Sadler JE. Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. Biochemistry 1991; 30: 253-69.
7. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-5.
8. Ginsburg D, Sadler JE. von Willebrand disease: a database of point mutations, insertions, and deletions. Thromb Haemost 1993; 69: 177-84.
9. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor, Proc Natl Acad Sci USA 1990; 87: 6306-10.
10. Marti T, Rösselet SJ, Titani K, Walsh KA. Identification of disulfide-bridged substructures within human von Willebrand factor. Biochemistry 1987; 26: 8099-109.
11. Bonthron D, On EC, Mitsock LM, Ginsburg D, Handin RI, Orkin SH. Nucleotide sequence of pre-pro-von Willebrand factor cDNA. Nucleic Acids Res 1986; 14: 7125-7.
12. Bonthron D, Orkin SH. The human von Willebrand factor gene. Structure of the 5′ region. Eur J Biochem 1988; 171: 51-7.
13. Sadler JE, Ginsburg D. A database of polymorphisms in the von Willebrand factor gene and pseudogene. Thromb Haemost 1993; 69: 185-91.
14. Ginsburg D, Konkle BA, Gill JC, Montgomery RR, Bockenstedt PL, Johnson TA, Yang AY. Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA. Pro Natl Acad Sci USA 1989; 86: 3723-7.
15. Lyons SE, Bruck ME, Bowie EJW, Ginsburg D. Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. J Biol Chem 1992; 267: 4424-30.
16. Sugiura I, Matsushita T, Tanimoto M, Takahashi I, Yamazaki T, Yamamoto K, Takamatsu J, Kamiya T, Saito H. Three distinct candidate point mutations of the von Willebrand factor gene in four patients with type IIA von Willebrand disease. Thromb Haemost 1992; 67: 612-7.
17. Inbal A, Seligsohn U, Kornbrot N, Brenner B, Harrison P, Randi A, Rabinowitz I, Sadler JE. Characterization of three mutations causing von Willebrand disease type IIA in five unrelated families. Thromb Haemost 1992; 67: 618-22.
18. Winter PC, Mayne EE. An alternative strategy for identification of type IIA vWD mutations. Br J Haematol 1993; 84: 521-3.
19. Lavergne J-M, De Paillette L, Bahnak BR, Ribba A-S, Fressinaud E, Meyer D, Pietu G. Defects in type HA von Willebrand disease: a cysteine 509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein Ib-IX. Br J Haematol 1992; 82: 66-72.
20. Inbal A, Englender T, Kornbrot N, Randi AM, Castaman G, Mannucci PM, Sadler JE. Identification of three candidate mutations causing type IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization method. Blood 1993; 82: 830-6.
21. 821→CYS) in the A2 region of the von Willebrand factor. Eur J Haematol 1993; 51: 38-44.
22. Sadler JE, Shelton-Inloes BB, Sorace JM, Harlan JM, Titani K, Davie EW. Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc Natl Acad Sci USA 1985; 82: 6394-8.
23. Shelton-Inloes BB, Titani K, Sadler JE. cDNA sequences for human von Willebrand factor reveal five types of repeated domains and five possible protein sequence polymorphisms. Biochemistry 1986; 25: 3164-71.
24. Randi AM, Rabinowitz I, Mancuso DJ, Mannucci PM, Sadler JE. Molecular basis of von Willebrand disease type IIB: candidate mutations cluster in one disulfide loop between proposed platelet glcoprotein Ib binding sequences. J Clin Invest 1991; 87: 1220-6.
25. Cooney KA, Nichols WC, Bruck ME, Bahou WF, Shapiro AD, Bowie EJW, Gralnick HR, Ginsburg D. The molecular defect in type IIB von Willebrand disease: identification of four potential missence mutations within the putative gpIb binding domain. J Clin Invest 1991; 87: 1227-33.
26. 545 substitution mutation of the von Willebrand factor in type IIB von Willebrand's disease. Eur J Haematol 1991; 47: 342-5.
27. Zhang ZP, Falk G, Blombäck M, Egberg N, Anvret M. Identification of a new nonsense mutation in the von Willebrand factor gene in patients with von Willebrand disease type III. Hum Mol Genet 1992; 1: 61-2.
28. Inbal A, Kornbrot N, Harrison P, Randi AM, Sadler JE. Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding-studies with recombinant von Willebrand factor. Thromb Haemost 1993; 70: 1058-62.